T1	Haplotype	0 20	In CYP3A5 * 1 allele
T2	Phenotype	32 49	CYP3A5 expressers
T3	Pharmacokinetic_phenotype	80 93	clearance was
T4	Phenotype	332 356	non-expressers ; however
T5	Limited_variation	378 391	variation did
T6	Pharmacokinetic_phenotype	417 441	chronopharmacokinetics .
R1	decreases	Arg1:T1	Arg2:T3
R2	influences	Arg1:T1	Arg2:T6
R3	isEquivalentTo	Arg1:T2	Arg2:T1
R4	decreases	Arg1:T2	Arg2:T3
R5	influences	Arg1:T2	Arg2:T6
R6	isAssociatedWith	Arg1:T3	Arg2:T1
R7	isAssociatedWith	Arg1:T3	Arg2:T2
R8	isAssociatedWith	Arg1:T3	Arg2:T4
R9	isAssociatedWith	Arg1:T3	Arg2:T5
R10	influences	Arg1:T4	Arg2:T1
R11	influences	Arg1:T4	Arg2:T2
R12	decreases	Arg1:T4	Arg2:T3
R13	influences	Arg1:T4	Arg2:T5
R14	influences	Arg1:T4	Arg2:T6
R15	influences	Arg1:T5	Arg2:T1
R16	influences	Arg1:T5	Arg2:T2
R17	influences	Arg1:T5	Arg2:T3
R18	influences	Arg1:T5	Arg2:T4
R19	influences	Arg1:T5	Arg2:T6
R20	isAssociatedWith	Arg1:T6	Arg2:T1
R21	isAssociatedWith	Arg1:T6	Arg2:T2
R22	decreases	Arg1:T6	Arg2:T3
R23	isAssociatedWith	Arg1:T6	Arg2:T4
R24	isAssociatedWith	Arg1:T6	Arg2:T5
